xAI's interplanetary ambitions and Modal Labs' significant valuation discussions highlight ongoing investment and strategic shifts in the AI sector, even as Elon Musk's xAI faces high-profile co-founder exits and experts discuss the brutal economics of orbital AI and how AI reshapes startup models.
OpenAI's disbandment of its mission alignment team and a researcher's departure over ChatGPT ads raise concerns about the company's commitment to safe AI development, alongside reports of an executive's firing amidst a discrimination claim linked to opposing an 'adult mode' chatbot.
Apple's Siri revamp faces further delays and the company releases iOS 26.3 updates benefiting non-Apple devices, while Uber Eats introduces an AI grocery assistant and Google launches Android 17 beta, and TikTok expands its Local Feed using precise location.
The resurgence of Lumma Stealer malware and Microsoft's warnings about critical zero-day exploits underscore persistent cyber threats, alongside the DOJ's case against a boss who sold exploits to a Russian broker and Google's ability to recover 'deleted' Nest video in a high-profile case.
Rocket Lab's engine testing involves intentional destruction deemed "not a big deal" by its CEO, while China demonstrates a new Moon ship and reusable rocket, and SpaceX gains "airline" status from the US, while federal authorities address "cartel" drones by closing airspace.
**Twilio's co-founder raises $450 million for a fusion power startup, Apptronik secures substantial funding for humanoid robots, and various startups like Integrate and Complyance attract millions** to innovate in defense project management, risk compliance, and financial modeling.
The passing of Byte magazine artist Robert Tinney marks the loss of a pioneer in visualizing personal computing, as Amazon Pharmacy expands same-day delivery, and an activist investor opposes the WBD-Netflix deal, amidst calls for nominations for the 2026 Joseph C. Belden Innovation Award.
A study suggests seabird guano fueled the rise of Peru's Chincha Kingdom, the Trump administration revokes a key climate change finding, and the FDA refuses to review Moderna's mRNA flu vaccine, highlighting developments in diverse scientific and policy areas.